About Us Portfolio Press Careers Sitemap Advertise Contact Us Make this your Homepage

Custom Search

Register

Sign In

Sign In Using Facebook

Home » Drug News

Research on MRSA Drug Halted by Novartis After Poor Tests

by Rajashri on August 30, 2008 at 2:30 PM Drug News

Research into Novartis' Aurograb treatment designed to combat bacterial infections such as the deadly MRSA bug is being halted by the company after disappointing clinical tests.

Research on MRSA Drug Halted by Novartis After Poor Tests

Related Links

The Swiss pharmaceutical giant said in a statement that it had decided to halt the programme "after Phase II results showed a lack of efficacy as an add-on therapy for life-threatening bacterial infections."

Novartis will take an impairment charge of 235 million dollars (159 million euros) in the third quarter as a result.

MRSA has shot to prominence in recent years as many people catch the bug while being treated in hospitals -- leading to doctors in Britain being banned from wearing their traditional white coats in favour of plastic aprons in a bid to reduce the risks of transmission.

Last June, the European Centre for Disease Prevention and Control (ECDC) warned that "healthcare-associated infections" such as MRSA, which are resistant to many antibiotics, are "possibly the biggest infectious disease challenge facing the EU."

It said that around three million people in the European Union catch a healthcare-associated infection every year and approximately 50,000 die as a result.

Source-AFP
RAS/L

Radioactive Leak in Belgium Worse Than Initially Thought

Report Says Millions of Young Chinese Addicted to 'unhealthy' Internet Games

More News on: Drug Toxicity, MRSA - The Super Bug, Drug Resistance - Antibiotic Resistance, Signature Drug Toxicity

Comment & Contribute

Be the first to comment!
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters
	Notify me when reply is posted I agree to the terms and conditions
Your comments are automatically posted once they are submitted. All comments are however constantly reviewed for spam and irrelevant material (such as product or personal advertisements, email addresses, telephone numbers and website address). Such insertions do not conform to our policy and 'Terms of Use' and are either deleted or edited and republished. Please keep your comments brief and relevant.This section may also have questions seeking help. If you have the information you are welcome to respond, but please ensure that the information so provided is genuine and not misleading.

Medwonders Health Network

Support Groups Members Discussions

Total Members - 54896
Support Groups - 445

Health News Index

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Latest News Most Popular Most Commented

Research Suggests Red Wine Alone may Not be the Elixir of Life

Babies' Health may be Compromised by the 'Too Posh to Push' Attitude

Research Sheds Light on Usefulness of Bubble-Propelled Microrockets

Broken Bones may be Fixed in Less Than 4 Weeks by 'Fracture Putty'

AIDS Drug Venture in South Africa Worth $208 Million

News Archive
Date :
Category :
Keyword :

News Quick Links

	News Central			Health Watch
	Latest Health News			Health In Focus
	News Category (500+)			Breaking Health News
	Popular News			Celebrating Life
	Health News and Press Release			Medindia - Exclusive
	News Photo Gallery			India Special
	News Video Gallery			Lifestyle and Wellness
	News From Other Resources

News Categories:


»	Trauma Patients Have High Risk of Vitamin D Deficiency

»	Bread and Dinner Rolls Have High Salt Levels: CDC

»	Latest Weight Loss Tip

»	Diabetes Diagnosis Triggers Unhealthy Diet Promotion Charge on US Celebrity Chef

»	Decaffeinated Coffee Could Improve Memory Function
More Diet News

Drug Related News
»	Research Says Financial Burden of Prescription Drugs is Dropping	»	New Guidelines to Avoid Heparin Contamination
»	Weight Loss Drug Has Killed At Least 1,300 in France	»	FDA Approves Sanofi�s Treatment for Head Lice
»	New Scoring Method may Help Decide Who Will Benefit From Stroke Drug	»	New Guidelines Recommend Metformin to Treat Type 2 Diabetes
»	Novel Prostate Cancer Drug Target Identified	»	Aspirin Helps Prevent DVT

Read More >>

Accident and Trauma Care Support Group	Acupuncture Support Group	Albinism / Hypopigmentation / Albinos Support Group
Alcohol abuse / Alcohol dependence / Alcoholism Support Group	Aromatherapy Support Group	Avian Influenza / Bird Flu Support Group
Ayurveda Support Group	Benign Prostatic Hyperplasia Support Group	Birth Defects - Metabolic Defects Support Group

Research on MRSA Drug Halted by Novartis After Poor Tests

Medwonders Health Network

Drug Related News

Consumers

Medical Professionals

Medical Students

Directories